The global pharmaceutical contract development and manufacturing market is projected to reach USD 146.1 billion by 2025 from USD 100.7 billion in 2020, at a CAGR of 7.7% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs. The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are also expected to offer market growth opportunities in the coming years. The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market, byend user, during the forecast period The pharmaceutical contract development and manufacturing market is segmented intobig pharmaceutical companies, small & medium-sized pharmaceutical companies, generic pharmaceutical companies, and other end users.The small and medium-sized pharmaceutical companies segment accounted for the highest growth rate in the pharmaceutical contract development and manufacturing market in 2020. This segment’s high growth can be attributed to the increasing number of emerging pharmaceutical companies that lack the in-house capabilities to manufacture and develop complex formulations and drug products.
Biologics manufacturing services segment accounted for the highest CAGR Based on service, the pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services.In 2020, the biologics manufacturing servicessegment accounted for the highest growth rate.
The major factor driving the growth of this segment is the growing demand for vaccines and biosimilars.
Asia Pacific: The fastest-growing countryin thepharmaceutical contract development and manufacturing market Thepharmaceutical contract development and manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.Asia Pacific is projected to register the highest CAGR during the forecast period.
This growth can be attributed to factors such as growth in the manufacturing sector, favorable government regulations, growing strategic expansions from leading companies, increasing emphasis on off-patent drugs, and the presence of a highly skilled workforce.
The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side- 80%and Demand Side 20% • By Designation: C-level - 25%, D-level - 20%, and Others - 55% • By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%
Lists of Companies Profiled in the Report: • Thermo Fisher Scientific Inc. (US) • Catalent, Inc. (US) • Lonza Group Ltd. (Switzerland) • Recipharm AB (Sweden) • Siegfried Holding AG (Switzerland) • WuXiAppTec (China) • Samsung Biologics (South Korea) • Boehringer Ingelheim International GmbH (Germany) • Piramal Pharma Solutions (India) • Vetter Pharma International GmbH (Germany) • FAMAR Health Care Services (France) • AbbVie Inc. (US) • Aenova Group (Germany) • Almac Group (UK) • Evonik Industries AG (Germany) • Cambrex Corporation (US) • CordenPharma International (Germany) • Albany Molecular Research Inc. (AMRI) (US) • FUJIFILM Corporation (Japan) • BioVectra (Canada)
Research Coverage: This report provides a detailed picture of thepharmaceutical contract development and manufacturing market.It aims at estimating the size and future growth potential of the market across different segments, such as the service, end user, and region.
The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical contract development and manufacturing marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
Our reports have been used by over 10K customers, including:
The Transdermal Skin Patches market is expected to register a CAGR of about 4.78% during the forecast period with a revenue of approximately USD 7244.33 million in 2020 and expected to reach USD 9572.34 million by 2026. The COVID-19 outbreak across the world is expected to have a positive impact on the transdermal skin patches market,...
The chromatography resin market size is estimated to be USD 2.2 billion in 2020 and is projected to reach USD 3.3 billion by 2025, at a CAGR of 8.2% between 2020 and 2025. Factors such as increasing demand for therapeutic antibodies, public-private investment in pharmaceutical & life science research, and rising concern for food safety will...
The pharmaceutical intermediate market was valued at US$ 27,356.70 million in 2020 and is projected to reach US$ 37,290.33 million by 2028; it is expected to grow at a CAGR of 4.2% from 2021 to 2028. The rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
240 pages •
By Asia Market Information & Development Company
• Apr 2021
China’s demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The market of Humic Acid is projected to grow at a CAGR of over 4% during the forecast period. The drivers of the market are its growing application in agriculture sector, and increasing usage in making animal feed. Various chemical counterparts and unfavorable conditions arising due to the COVID-19 outbreak are the restraints that hinder...
The Veterinary Pain management market was valued at USD 1,197 million in 2020, and it is expected to reach USD 1,910 million in 2026, registering a CAGR of nearly 6.30% during the forecast period. The global outbreak of COVID-19 has impacted all industries including veterinary pain medicine. Pet parents are advised to keep a safe distance...
531 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• May 2021
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development, manufacturing, and formulation due to rise in population, increase in chronic diseases like infectious diseases, oncology, cardiovascular disorders, rising healthcare expenditures, collaborations,...
249 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...
India - Healthcare, Regulatory and Reimbursement Landscape Summary The analyst has released its latest report: “India - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in India. It...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.